In September 2023, the FDA classified BPC-157 as a Category 2 compound under the 503A bulking list, restricting its use by American compounding pharmacies
These include [6, 34, 39]: Irritation at the site of injection Fatigue Nausea Light-headedness Sweatin g Adverse effects are often attributable to low-grade peptides
(1) Cox HD, Smeal SJ, Hughes CM, Cox JE, Eichner D
Although not directly targeting musculoskeletal tissue, epithalon's systemic benefits, such as improved sleep quality and hormonal regulation, may indirectly support recovery by enhancing endogenous GH secretion and reducing oxidative stress
Repeat determinations of iron and folic acid may reveal a complicating illness that might inhibit the response of the marrow
High Purity 99% Purity Guaranteed Every batch is independently lab tested for identity, purity and potency